#1241950
AstraZeneca Pharmaceuticals #00310662702

SYMLIN® Pramlintide acetate 2700 mg / 2.7 mL Injection 2.7 mL 2 Prefilled Injection Pens

Name: Antidiabetic Agent
Brand: SYMLIN®

SYMLIN, PEN 120INJ 2700MG/2.7ML (2/CT)

No Image

Compare

Product Specifications

McKesson #

1241950

Manufacturer #

00310662702

Brand

SYMLIN®

Manufacturer

AstraZeneca Pharmaceuticals

Country of Origin

Belgium

Alternate Manufacturer Number

3411071

Application

Antidiabetic Agent

Container Type

Prefilled Injection Pen

Dosage Form

Injection

Generic Drug Code

99450

Generic Drug Name

Pramlintide acetate

NDC Number

00310662702

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

2 Prefilled Injection Pens

Storage Requirements

Requires Refrigeration

Strength

2700 mg / 2.7 mL

Type

Subcutaneous

UNSPSC Code

51183620

Volume

2.7 mL

Features

SYMLIN is an amylin analog indicated for patients with type 1 or type 2 diabetes who use mealtime insulin and have failed to achieve desired glycemic control despite optimal insulin therapy

Professionals Also Viewed

View Full Comparison

No Image

#1104092
Boehringer Ingelheim #00597015290

Jardiance® Empagliflozin 10 mg Tablet 90 Tablets

#993729
AstraZeneca Pharmaceuticals #00310621030

Farxiga® Dapagliflozin Propanediol 10 mg Tablet 30 Tablets

Type 2 Diabetes Medication for Adults
Film Coated

No Image

#1104093
Boehringer Ingelheim #00597015390

Jardiance® Empagliflozin 25 mg Tablet 90 Tablets

#574097
Mylan Pharmaceuticals #00378021501

Tolbutamide 500 mg Tablet 100 Tablets